FDA Inspection 1207801 — Ajinomoto Omnichem
The FDA completed an inspection of Ajinomoto Omnichem on December 16, 2022 in Balen. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- December 16, 2022
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Balen (Belgium)
Additional Details
Mutual Recognition Agreement (MRA)